drugset / Trial / NCT01173770

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ADC3680B in Healthy Volunteers

NCT01173770 ↗

Phase 1 Completed 52 enrolled Pulmagen Therapeutics
RandomizedCrossoverDouble-blindTreatment

Summary

This is a First-In-Man study designed to examine the safety, tolerability, pharmacokinetics and functional activity of ADC3680B after single and multiple doses in healthy male volunteers.

Timeline

Start
2010-07
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject ADC3680B Unknown — Oral

Indications

No indication recorded.